Atomos has released its Quarterly Activities/Appendix 4C Cash Flow Report. This Report is for the three-month period that ...
Highlights New analysis of ATH434-201 double blind trial strengthens efficacy signal at high dose levelPositive data from ATH434-202 open-label trial demonstrates similar treatment effect in advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback